Frank Witney Named CEO and President at Affymetrix as Kevin King Resigns

Witney most recently served as president and CEO of Dionex and oversaw its $2.1 billion sale to Thermo Fisher Scientific earlier this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.